Development and Evaluation of an Online Shared Decision-Making Educational Program for Nurses and Patients With Chronic Diseases
21. května 2026 aktualizováno: Myonghwa Park, Chungnam National University
This study aims to develop and evaluate an online shared decision-making (SDM) educational program for nurses and patients with chronic diseases.
Shared decision-making is a process in which healthcare professionals and patients make health-related decisions together based on the best available evidence and the patient's values and preferences.
The study includes an evaluation phase.
In the evaluation phase, the program will be tested among nurses working in general hospitals and adults with chronic diseases living in the community.
Outcomes related to shared decision-making will be assessed at baseline, immediately after the 4-week program, and 1 month later.
The study is expected to improve shared decision-making competence, experience, and preparedness among both nurses and patients.
Přehled studie
Postavení
Nábor
Podmínky
Intervence / Léčba
- Behaviorální: Online Shared Decision-Making Educational Program for Nurses
- Behaviorální: Online Shared Decision-Making Educational Program for Patients With Chronic Diseases
- Behaviorální: General Communication Education for Nurses
- Behaviorální: General Health Information for Patients With Chronic Diseases
Detailní popis
Shared decision-making is a key component of patient-centered care and is particularly important in chronic disease management, where patients often face repeated decisions about treatment options, symptom management, lifestyle modification, and long-term care.
Effective shared decision-making requires healthcare professionals and patients to exchange information, consider available options, and make decisions that reflect both clinical evidence and patient values and preferences.
Nurses play an important role in chronic disease care by providing education, coordinating communication, and supporting patient participation in health-related decision-making.
Patients with chronic diseases also need support to understand their options, clarify their values, and participate actively in decisions about their care.
However, structured educational opportunities to strengthen shared decision-making competence are limited for both nurses and patients.
This study will develop an online shared decision-making educational program for nurses and patients with chronic diseases and will evaluate its effectiveness in two parallel sub-studies.
For nurses, the study will be conducted as a cluster-randomized pretest-posttest controlled trial in general hospitals in Daejeon and Chungcheong-do, Republic of Korea.
Hospitals will serve as clusters, and one hospital will be assigned to the intervention group and the other to the control group by coin toss conducted by a third researcher who is not involved in study implementation or data analysis.
For patients with chronic diseases, the study will be conducted as a cluster-randomized pretest-posttest controlled trial in community health and welfare institutions.
Institutions will serve as clusters and will be assigned in a 1:1 ratio to intervention or control conditions using a computer-generated random allocation sequence prepared by a third researcher not involved in study implementation or data analysis.
The intervention will consist of a 4-week online SDM educational program delivered through a web-based platform.
Nurses in the intervention group will receive an online program consisting of 12 educational videos.
Patients in the intervention group will receive an online program consisting of 5 educational videos.
Control participants will receive comparison materials according to the study protocol.
Outcome measures will be collected at baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment.
The study will evaluate whether the program improves shared decision-making-related competence, experience, knowledge, decisional preparedness, and related outcomes in the two target populations.
Typ studie
Intervenční
Zápis (Odhadovaný)
288
Fáze
- Nelze použít
Kontakty a umístění
Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.
Studijní kontakt
- Jméno: Geunyoung Lee
- Telefonní číslo: +82 42-580-8407
- E-mail: lgy2513@gmail.com
Studijní místa
-
-
-
Daejeon, Jižní Korea, 35015
- Nábor
- Chungnam National University
-
-
Kritéria účasti
Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Ne
Popis
Inclusion Criteria for Nurse:
- Registered nurses currently providing direct patient care in participating general hospitals
- Able to understand the purpose and procedures of the study and provide informed consent
- Able to use a computer, tablet, or smartphone to access the online program
Exclusion Criteria for Nurse:
- Not currently engaged in direct patient care
- Unable to clearly express willingness to participate
- Unable to complete the educational program or questionnaires because of technical or language limitations
Inclusion Criteria for Patients:
- Adults aged 19 years or older living in the community
- Diagnosed with one or more chronic diseases requiring ongoing management, including but not limited to hypertension, diabetes mellitus, dyslipidemia, arthritis, chronic respiratory disease, or cardiovascular disease, with at least 3 months elapsed since diagnosis
- Able to understand the purpose and procedures of the study and provide informed consent
- Able to read and respond to survey questions
- Able to use a computer, tablet, or smartphone to access the online program
Exclusion Criteria for Patients:
- Cognitive impairment or communication problems that make participation difficult
- Unable to complete the educational program or questionnaires because of technical or language limitations
Studijní plán
Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.
Jak je studie koncipována?
Detaily designu
- Primární účel: Podpůrná péče
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Online SDM Educational Program Group
Participants will receive access to a web-based shared decision-making educational program tailored for nurses or patients with chronic diseases for 4 weeks.
|
The nurse program is a 4-week web-based shared decision-making educational program for nurses working in general hospitals.
It is designed to enhance nurses' knowledge and skills in shared decision-making, decision support, and patient communication through self-directed online learning.
The patient program is a 4-week web-based shared decision-making educational program for adults with chronic diseases.
It is designed to support patients in participating in shared decision-making by helping them prepare for decisions, explore options, and clarify their values and preferences.
|
|
Aktivní komparátor: Control Group
Participants will be provided access to publicly available comparison materials during the 4-week study period.
|
The control condition consists of access to publicly available communication-related educational materials, such as those provided by the Nursing Human Resources Employment Education Center.
The control condition consists of access to publicly available health management information, such as that provided by the National Health Information Portal.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Change in nurses' shared decision-making competence
Časové okno: Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
|
Nurses' shared decision-making competence will be assessed using a shared decision-making competence scale for nurses.
The scale consists of 26 items with total scores ranging from 26 to 130. Higher scores indicate greater shared decision-making competence.
Changes in scores from baseline to each follow-up assessment will be compared between the intervention and control groups.
|
Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
|
|
Change in patients' shared decision-making experience
Časové okno: Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
|
Patients' shared decision-making experience will be assessed using the Shared Decision-Making Questionnaire-9 items(SDM-Q-9).
The SDM-Q-9 consists of 9 items, with total raw scores ranging from 0 to 45. Higher scores indicate a greater level of patient-perceived shared decision-making.
Changes in scores from baseline to each follow-up assessment will be compared between the intervention and control groups.
|
Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Change in nurses' shared decision-making experience
Časové okno: Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
|
Nurses' perceived shared decision-making practice will be assessed using the Shared Decision-Making Questionnaire-Physician version(SDM-Q-Doc).
The SDM-Q-Doc consists of 9 items, with total raw scores ranging from 0 to 45. Higher scores indicate a greater level of clinician-perceived shared decision-making.
Changes in scores across assessment points will be compared between the intervention and control groups.
|
Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
|
|
Change in patients' decisional conflict
Časové okno: Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
|
Patients' decisional conflict will be assessed using the Decision Conflict Scale(DCS) Korean version.
Scores range from 0 to 100, with higher scores indicating greater decisional conflict.
Therefore, lower scores indicate a better outcome.
Changes in scores across assessment points will be compared between the intervention and control groups.
|
Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment
|
|
Change in shared decision-making knowledge
Časové okno: Baseline and immediately after the 4-week intervention
|
Shared decision-making knowledge and understanding of the educational content will be assessed using pre- and post-program quizzes developed for each study population.
For nurses, the quiz consists of 24 items, and the number of correct answers will range from 0 to 24.
For patients, the quiz consists of 10 items, and the number of correct answers will range from 0 to 10.
A higher number of correct answers indicates greater knowledge and understanding of the educational content.
Changes in the number of correct answers from baseline to post-intervention will be compared between the intervention and control groups.
|
Baseline and immediately after the 4-week intervention
|
|
Preparation for decision making after the intervention
Časové okno: Immediately after the 4-week intervention and 1 month after the first post-intervention assessment
|
Preparation for decision making will be assessed using the Preparation for Decision Making(PrepDM), including the practitioner version for nurses and the participant version for patients, as applicable.
Scores range from 0 to 100, with higher scores indicating a higher perceived level of preparation for decision making.
Scores will be compared between the intervention and control groups after the intervention and at follow-up.
|
Immediately after the 4-week intervention and 1 month after the first post-intervention assessment
|
Spolupracovníci a vyšetřovatelé
Zde najdete lidi a organizace zapojené do této studie.
Sponzor
Termíny studijních záznamů
Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.
Hlavní termíny studia
Začátek studia (Odhadovaný)
10. května 2026
Primární dokončení (Odhadovaný)
10. července 2026
Dokončení studie (Odhadovaný)
3. dubna 2027
Termíny zápisu do studia
První předloženo
10. května 2026
První předloženo, které splnilo kritéria kontroly kvality
10. května 2026
První zveřejněno (Aktuální)
15. května 2026
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
26. května 2026
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
21. května 2026
Naposledy ověřeno
1. května 2026
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 202511-SB-236-01
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
NE
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Ne
Studuje produkt zařízení regulovaný americkým úřadem FDA
Ne
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .